Daniel T. Sloper Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

NCTR

Last publication 2024 Last refreshed 2026-05-16

faculty

12 h-index 39 pubs 437 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Daniel T. Sloper's research investigates the molecular and cellular mechanisms underlying disease, with a particular focus on reproductive health and inflammation. His work has explored the identification of altered proteins in rat models of chronic prostatic inflammation induced by sex hormones, as detailed in his 2021 publications. He has also studied the effects of estradiol and testosterone on gene expression in prostate spheroid models. Additionally, Sloper has contributed to research on bone health, examining the coadministration of black cohosh extract and risedronate in an ovariectomized rat model, as published in 2024. His research also extends to cancer therapeutics, including the investigation of WL-276, an antagonist against Bcl-2 proteins, for its potential to overcome drug resistance and suppress prostate tumor growth, as reported in 2023. Sloper has a history of collaboration with researchers at the National Center for Toxicological Research, including Noriko Nakamura, with whom he shares four publications.

Metrics

h-index: 12
Publications: 39
Citations: 437

Selected Publications

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024)

2 citations DOI OpenAlex
Altered expression of genes identified in rats with prostatic chronic inflammation in a prostate spheroid model treated by estradiol/testosterone (2021)

2 citations DOI OpenAlex
Identification of Altered Proteins in the Plasma of Rats With Chronic Prostatic Inflammation Induced by Estradiol Benzoate and Sex Hormones (2021)

3 citations DOI OpenAlex
Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans (2021)

5 citations DOI OpenAlex